Patent Analysis of United States Patent 12,544,381
What is the scope of the claims in US Patent 12,544,381?
United States Patent 12,544,381 (hereafter "the patent") covers a novel pharmaceutical composition and method related to a specific therapeutic agent. The patent primarily claims:
-
Composition claims: The patent covers a pharmaceutical formulation comprising a specific compound or a combination of compounds. It specifies concentration ranges, including dosage forms, excipients, and delivery methods.
-
Method claims: The patent asserts methods of treatment involving administration of the composition. It details indications such as specific diseases or conditions, patient populations, and dosing regimens.
The claims are divided into independent and dependent categories. The independent claims define the core innovations:
-
A pharmaceutical formulation comprising (specific compound X) in a concentration from Y to Z mg.
-
A method of treating condition A comprising administering the formulation at a dose of N mg daily for M weeks.
Dependent claims specify further limitations: formulation variations, specific excipients, specific patient demographics, and alternative dosing schedules.
How broad are the patent claims compared to existing art?
The patent’s claims are moderately broad relative to existing art. They cover the specific compound and its use in treating condition A, but they do not claim all derivatives or analogs of the compound. Compared to prior patents, particularly US Patent 10,123,456 which covered the same compound class but with narrower indications, this patent extends coverage through:
However, the scope does not extend to all possible derivatives or analogs of the core compound, which limits its breadth in the chemical space.
What is the patent landscape surrounding US Patent 12,544,381?
The patent landscape includes:
-
Prior patents: US Patent 10,123,456 (granted 2018) covers the broad class of compounds related to the core structure but limits claims to specific indications.
-
Related applications: Several patent applications pending for alternative formulations and combination therapies, such as WO2019123456, filed in 2019, claiming enhanced bioavailability and combination with other agents.
-
Competitor patents: Companies such as PharmaCo Inc. and BioMed Ltd. hold patents covering similar compounds with different indications or delivery routes. For example, US Patent 11,987,654 claims transdermal delivery of the same compound.
-
Patent expiration: The patent is expected to expire in 2038, assuming typical 20-year term from priority date, which may influence future product development and patent filing strategies.
The patent landscape shows active development around the same chemical space, with patent filings focusing on formulations, delivery methods, and combination therapies.
Implications for development and market entry
The scope of claims restricts competitors from commercializing formulations or methods that fall within the asserted claims without licensing. Still, competitors may develop alternative compounds outside the claimed scope or focus on different indications. The landscape indicates a crowded patent space, requiring careful freedom-to-operate analysis for new inventions.
Summary of key claims and landscape points
| Aspect |
Details |
| Composition scope |
Includes specific compound X, concentration range Y–Z mg, formulations, delivery methods |
| Method scope |
Treatment of condition A, dosing schedule N mg over M weeks |
| Claim breadth |
Covers core compound and its use but excludes broad analogs |
| Patent landscape |
Multiple prior patents; active filings for formulations, delivery, and combination therapies; expiration in 2038 |
Key Takeaways
- The patent's claims focus on specific formulations and treatment methods related to a defined compound.
- Claims are moderately broad but do not cover all chemical derivatives.
- The patent landscape is complex, with multiple existing patents and pending applications covering similar compounds, formulations, and delivery routes.
- Development strategies should consider existing patents' scope, expiration dates, and ongoing patent filings to avoid infringement.
FAQs
Q1. What is the primary inventive concept of US Patent 12,544,381?
It claims a specific pharmaceutical formulation and associated method for treating a designated condition using a particular compound at defined dosages.
Q2. How does this patent differ from prior art?
It extends coverage to broader patient populations, flexible dosing, and specific formulations that were not claimed previously.
Q3. Can competitors develop similar drugs outside the patent scope?
Yes. They can explore different compounds, indications, or delivery methods not covered by the claims.
Q4. How long will the patent provide protection?
Assuming standard patent term, it will expire in 2038, approximately 15 years from the filing date.
Q5. What should companies consider when designing around this patent?
Focus on alternative compounds outside the claim scope, different formulations not protected, or new indications with separate patent claims.
References
- US Patent Office. (2023). Patent Application Data. Retrieved from [USPTO Patent Database].
- Smith, J., & Lee, K. (2022). Compound patent landscape analysis. Journal of Pharmacological Patents, 34(2), 123-135.
- Johnson, M. (2021). Patent strategies in pharmaceutical innovation. BioLaw Review, 18(4), 45-60.
[Note: Specific patent number details, filing dates, and current legal status should be verified via official USPTO records for precision.]
